Sendero Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.46M Sell
9,387
-8
-0.1% -$2.05K 0.25% 64
2026
Q2
$2.36M Buy
9,395
+713
+8% +$153K 0.24% 72
2026
Q1
$1.89M Sell
8,682
-513
-6% -$114K 0.21% 71
2025
Q4
$2.1M Sell
9,195
-59
-0.6% -$13.4K 0.23% 67
2025
Q3
$2.14M Sell
9,254
-35
-0.4% -$7.13K 0.25% 63
2025
Q2
$1.72M Sell
9,289
-36
-0.4% -$6.69K 0.22% 71
2025
Q1
$1.95M Buy
9,325
+2,074
+29% +$403K 0.27% 60
2024
Q4
$1.29M Buy
7,251
+706
+11% +$130K 0.19% 77
2024
Q3
$1.29M Sell
6,545
-1,872
-22% -$349K 0.2% 66
2024
Q2
$1.44M Sell
8,417
-35
-0.4% -$5.8K 0.24% 59
2024
Q1
$1.54M Buy
8,452
+66
+0.8% +$11.4K 0.26% 62
2023
Q4
$1.3M Buy
8,386
+387
+5% +$56.4K 0.25% 68
2023
Q3
$1.19M Buy
7,999
+1
+0% +$147 0.26% 68
2023
Q2
$1.08M Buy
+7,998
New +$1.17M 0.24% 75

Other funds holding ABBV

Sendero Wealth Management's ABBV Position: Q3 2026 in Review

Sendero Wealth Management reduced its AbbVie (ABBV) stake by 0.09% in Q3 2026, selling an estimated $2.05K and leaving 9,387 shares worth $2.46M. The position accounts for 0.25% of the portfolio, ranked #64.

Sendero Wealth Management first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sendero Wealth Management held 9,387 shares of AbbVie worth $2.46M as of Q3 2026.
  • Sendero Wealth Management sold 8 AbbVie shares in Q3 2026, an estimated $2.05K.
  • AbbVie made up 0.25% of Sendero Wealth Management's portfolio in Q3 2026, its #64 holding.
  • Sendero Wealth Management first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sendero Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.